For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...

Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

As symptoms worsen, they often spread throughout ... thereby providing therapeutic effects for patients with severe myasthenia gravis mediated by autoantibodies. It received approval from the ...

Here's what to know about flu symptoms in 2025, how to tell if it's something else, and how to protect yourself: But there are some differences. COVID-19 can show up later than the cold or flu ...

Languages: English. Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body ...